William L. Elliott

Pfizer (United States) — United States

Medicine · Health Sciences

23h-index3.1kcitations61works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(14), Quinazolinone synthesis and applications(10), Synthesis and biological activity(8), Synthesis and Characterization of Heterocyclic Compounds(7), Monoclonal and Polyclonal Antibodies Research(6)

Publications61 total

ChemInform Abstract: Design and Synthesis of 2‐Nitroimidazoles with Variable Alkylating and Acylating Functionality.
ChemInform·2014
Design and Synthesis of 2-Nitroimidazoles with Variable Alkylating and Acylating Functionality
Chemical and Pharmaceutical Bulletin·2014· 5 citedOpen Access
Abstract 5242: Bioluminescence imaging of radiation induced tumor growth inhibition in orthotopic mouse models
Cancer Research·2010
Abstract 5243: Value of 1H magnetic resonance spectroscopy compared with anatomical imaging in predicting response to standard chemotherapy and radiation in U87-MG-luc intracranial glioma model
Cancer Research·2010
Criterion validity of a computer-based tutorial for teaching waist circumference self-measurement
Journal of Bodywork and Movement Therapies·2008· 9 cited
Preclinical Models of Tumor Growth and Response
Humana Press eBooks·2007· 8 cited
Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors
Journal of Medicinal Chemistry·2006· 79 citedOpen Access
Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor
Molecular Cancer Therapeutics·2005· 12 cited
MRI predicts tumor grade and survival in a tv-a transgenic model of glioma
Cancer Research·2005
Pyrido[2,3-<i>d</i>]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4
Journal of Medicinal Chemistry·2005· 148 citedOpen Access
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts
Molecular Cancer Therapeutics·2004· 1.2k cited
67 Assessment of treatment efficacy in preclinical drug testing using magnetic resonance imaging
European Journal of Cancer Supplements·2004
High field MRI characterization of tumor growth kinetics, vascularity and cellularity in a PDGF-driven RCAS/tv-a mouse model of glioma
Cancer Research·2004
Role of vitamin C in collagen biosynthesis and connective tissue health
Journal of Bodywork and Movement Therapies·2002· 3 cited
Role of vitamin C in collagen biosynthesis and connective tissue health
Journal of Bodywork and Movement Therapies·2002
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer
Seminars in Oncology·2002· 71 cited
CI-1033, a pan-erbB tyrosine kinase inhibitor
Seminars in Oncology·2001· 17 cited
Exercise physiology perspective
Journal of Bodywork and Movement Therapies·2001· 1 cited
Soluble 2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7-yl Ureas. Structure−Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity
Journal of Medicinal Chemistry·2001· 53 citedOpen Access
Tyrosine Kinase Inhibitors. 18. 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines as Soluble, Irreversible Inhibitors of the Epidermal Growth Factor Receptor
Journal of Medicinal Chemistry·2000· 89 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

David W. Fry(14), H. D. Hollis Showalter(14), Patrick W. Vincent(14), Wilbur R. Leopold(13), Alan J. Kraker(9), William A. Denny(8), Billy Roberts(8), James M. Nelson(7), James M. Hamby(5), Wayne D. Klohs(5), Gina H. Lu(5), Curtis T. Howard(5), Bill J. Roberts(5), W R Leopold(5), Peter Heinstein(5), Jeff B. Smaill(4), S. KLUTCHKO(4), Brian G. Hartl(4), Denise L. Driscoll(4), Donald J. Dykes(4)